Dare bioscience, inc. (DARE)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Operating activities:
Operating activities:
Net Income (Loss) Attributable to Parent

-14,263

-16,738

-11,503

-672

-39,594

-23,342

-17,143

-22,101

Non-cash adjustments reconciling net loss to operating cash flows:
Depreciation

11

2

0

-

-

-

-

-

Stock-based compensation

462

139

15

9

2,375

885

622

529

Non-cash operating lease cost

-29

9

-

-

-

-

-

-

Noncash rent expense

-

-

-

-

-41

29

-1

-68

Change in carrying value of preferred stock warrant liability

-

-

-

-

-

-504

-202

-39

Depreciation and amortization

-

-

-

-

192

126

197

346

Loss on extinguishment of debt

-

-

-

-

-

-2,493

-

-

Amortization of debt discount and deferred financing costs

-

-

-

-

739

215

215

-

Loss on disposal of property and equipment

-

-

-

-

6

28

-7

-2

Non-cash interest

-

-

316

-

-

-

-

61

Acquisition-related IPR&D

-202

507

0

-

-

-

-

-

Impairment of goodwill

0

5,187

7,500

-

-

-

-

-

Changes in operating assets and liabilities:
Other receivables

201

-253

-662

-

-

-

-

-

Accounts receivable, prepaid expenses and other current assets

-

-

-

-

-

-

-

61

Prepaid expenses

322

91

113

-250

-

-

-

-

Other current assets

0

-193

193

-

-

-

-

-

Other non-current assets and deferred charges

-237

-145

2

-

-

-

-

-

Accounts receivable, prepaid expenses and other current assets

-

-

-

-

-342

695

209

-

Accounts payable

608

151

218

-0

795

341

14

-163

Accrued expenses

621

-27

534

-

3,283

1,419

-114

489

Deferred grant funding

238

0

-

-

-

-

-

-

Interest payable

-

-

33

42

-

-

-

-

Deferred rent

-

-

0

-

-

-

-

-

Net cash used in operating activities

-13,315

-10,268

-2,540

-

-

-

-

-

Net cash used in operating activities

-

-

-

-372

-31,915

-19,061

-16,614

-21,005

Investing activities:
Acquisition of Microchips cash

6,143

0

-

-

-

-

-

-

Cash acquired through merger

-

-

9,918

-

-

-

-

-

Purchases of property and equipment

0

11

0

-

277

225

7

180

Acquisition of Pear Tree and Hydra assets

0

507

0

-

-

-

-

-

Net cash provided by (used in) investing activities

6,143

-518

9,918

-

-

-

-

-

Financing activities:
Proceeds from sale of property and equipment

-

-

-

-

23

40

-

-

Decrease in restricted cash

-

-

-

-

230

-

-

-

Net cash provided by investing activities

-

-

-

0

-484

-185

-7

-180

Financing activities:
Proceeds from the exercise of common stock warrants

5,151

10,111

0

-

-

-

-

-

Proceeds from sale of common stock

-

-

-

-

2,628

140

35

3

Proceeds from public stock offering, net

-

-

-

-

37,185

59,862

-

-

Proceeds from loan payable

-

-

-

-

21,000

-

-

10,000

Proceeds from issuance of convertible promissory notes

-

-

155

197

-

8,500

8,824

-

Net cash provided by financing activities

5,151

10,111

155

-

-

-

-

-

Effect of exchange rate changes on cash and cash equivalents

-5

-78

-

-

-

-

-

-

Net change in cash and cash equivalents

-2,025

-753

-

-

-

-

-

-

Payments on capital lease

-

-

-

-

-

-

-

3

Payments on loan payable

-

-

-

-

3,321

3,348

3,084

376

Cash paid for debt issuance costs

-

-

-

-

359

222

373

4

Proceeds from sale of redeemable convertible preferred stock, net of issuance costs

-

-

-

-

-

-

-

12,927

Net cash provided by financing activities

-

-

-

197

57,133

64,932

5,402

22,547

Effect of exchange rate changes on cash and cash equivalents

-

-

-18

-

-

-

-

-

Net change in cash and cash equivalents

-

-

7,515

-

24,734

45,686

-11,219

1,362

Shares issued in connection of business combination and assumed equity awards

-

-

24,279

-

-

-

-

-

Purchase of property and equipment in accounts payable

-

-

-

-

177

-

-

-

Conversion of redeemable convertible preferred stock into common stock

-

-

-

-

-

81,526

2,226

-

Conversion of convertible notes into common stock

-

-

912

-

-

20,129

-

-

Supplemental disclosure of non-cash operating and financing activities:
Operating right-of-use assets obtained in exchange for new operating lease liabilities

583

-

-

-

-

-

-

-

Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount

789

0

-

-

-

-

-

-

Microchips acquisition consideration paid in equity

2,369

0

-

-

-

-

-

-

Cash paid for income taxes

-

-

0

-

-

-

-

-

Reclassification of warrants to additional paid-in capital

-

-

-

-

-

424

-

-

Warrants issued with term loan facility

-

-

-

-

824

-

-

-

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

-

73

Fair value of preferred stock warrants issued in connection with debt

-

-

-

-

-

-

-

360

Supplemental cash flow information  Interest paid

-

-

-

-

1,000

400

664

507

Net decrease in cash

-

-

-

-174

-

-

-

-